Infection prevention and control (IPC) strategies against COVID-19 include social distancing and isolating infected patients.
The clinical management of pandemic settings relies on enabling telemedicine associated to disease diagnosis and monitoring.
OTelemedicine has become common practice for monitoring of individual vital signs (VS) and patient status at isolation rooms.
Optical and biophotonic technologies have potential to improve treatment outcome and increase survival rates.
Biophotonic telemedicine advancements should focus on the development of reliable and user-friendly technology.